Cardiol Therapeutics CRDL Stock
Cardiol Therapeutics Price Chart
Cardiol Therapeutics CRDL Financial and Trading Overview
| Cardiol Therapeutics stock price | 1.12 USD |
| Previous Close | 1.22 USD |
| Open | 1.22 USD |
| Bid | 0.9 USD x 200 |
| Ask | 1.54 USD x 200 |
| Day's Range | 1.2 - 1.27 USD |
| 52 Week Range | 0.88 - 1.71 USD |
| Volume | 414.15K USD |
| Avg. Volume | 675.73K USD |
| Market Cap | 140.63M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.28 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.3 USD |
CRDL Valuation Measures
| Enterprise Value | 105.41M USD |
| Trailing P/E | N/A |
| Forward P/E | -6.012008 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 7.5870786 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.965 |
Trading Information
Cardiol Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -1.61% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 1.71 USD |
| 52 Week Low | 0.88 USD |
| 50-Day Moving Average | 1.32 USD |
| 200-Day Moving Average | 1.12 USD |
CRDL Share Statistics
| Avg. Volume (3 month) | 675.73K USD |
| Avg. Daily Volume (10-Days) | 316.37K USD |
| Shares Outstanding | 115.27M |
| Float | 94M |
| Short Ratio | 3.06 |
| % Held by Insiders | 2.38% |
| % Held by Institutions | 24.91% |
| Shares Short | 1.96M |
| Short % of Float | 1.75% |
| Short % of Shares Outstanding | 1.70% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -78.24% |
| Return on Equity (ttm) | -173.96% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -35554304 USD |
| Net Income Avi to Common (ttm) | -36349808 USD |
| Diluted EPS (ttm) | -0.28 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 27.67M USD |
| Total Cash Per Share (mrq) | 0.25 USD |
| Total Debt (mrq) | 116.41K USD |
| Total Debt/Equity (mrq) | 0.48 USD |
| Current Ratio (mrq) | 4.387 |
| Book Value Per Share (mrq) | 0.16079971 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24218514 USD |
| Levered Free Cash Flow (ttm) | -13746113 USD |
Profile of Cardiol Therapeutics
| Country | United States |
| State | ON |
| City | Oakville |
| Address | 2265 Upper Middle Road East |
| ZIP | L6H 0G5 |
| Phone | 289 910 0850 |
| Website | https://www.cardiolrx.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 18 |
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Q&A For Cardiol Therapeutics Stock
What is a current CRDL stock price?
Cardiol Therapeutics CRDL stock price today per share is 1.12 USD.
How to purchase Cardiol Therapeutics stock?
You can buy CRDL shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cardiol Therapeutics?
The stock symbol or ticker of Cardiol Therapeutics is CRDL.
Which industry does the Cardiol Therapeutics company belong to?
The Cardiol Therapeutics industry is Drug Manufacturers - Specialty & Generic.
How many shares does Cardiol Therapeutics have in circulation?
The max supply of Cardiol Therapeutics shares is 115.27M.
What is Cardiol Therapeutics Price to Earnings Ratio (PE Ratio)?
Cardiol Therapeutics PE Ratio is now.
What was Cardiol Therapeutics earnings per share over the trailing 12 months (TTM)?
Cardiol Therapeutics EPS is -0.28 USD over the trailing 12 months.
Which sector does the Cardiol Therapeutics company belong to?
The Cardiol Therapeutics sector is Healthcare.
Cardiol Therapeutics CRDL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}